The global incidence of severe acute respiratory virus coronavirus 2 (SARS-CoV-2) infection continues to increase daily. To date, many urological centres have prioritised their patients for urgent surgical intervention because of a reduction in operating theatre availability and the risk of hospital-acquired SARS-CoV-2 infection [@bib0005], [@bib0010]. The first confirmed case of SARS-CoV-2 infection in the Republic of Ireland was diagnosed on February 29, 2020 and as of May 8, 2020, there have been 22 385 confirmed COVID-19 cases, which represents a case rate of 453.3 per 100 000 population [@bib0015]. Here we present our perioperative outcomes for patients undergoing urological surgery during the initial stage of the SARS-CoV-2 pandemic in Ireland (between March 16 and May 1, 2020, inclusive).

Our hospital has an onsite microbiology laboratory that performs daily SARS-CoV-2 real-time reverse-transcription polymerase chain reaction testing. Our screening policies for elective and emergency urology patients are detailed in the Supplementary material. During the initial 7-wk period of the SARS-CoV-2 pandemic, 101 urological procedures were performed: 73 urgent elective (age 62 ± 13 yr, and American Society of Anesthesiologists \[ASA\] score 2.65 ± 0.56) and 32 emergency cases (age 51 ± 20 yr, ASA score 1.68 ± 0.82). Elective surgery was prioritised according to recent European guidelines and patients were then placed on a centralised departmental theatre waiting list [@bib0005]. Details on all elective and emergency urological procedures are summarised in Supplementary Table 1 and Supplementary Table 2, respectively.

In total, seven patients (7/101, 7%) developed symptoms of SARS-CoV-2 infection during the postoperative period, of whom three male patients (3/101, 3%) were diagnosed with symptomatic SARS-CoV-2 infection. All three SARS-CoV-2--positive patients developed significant postoperative pulmonary complications (Supplementary Fig. 1) and one patient died. The remaining four patients were subsequently diagnosed with pyelonephritis (*n* = 1) or postoperative atelectasis (*n* = 3) after a negative SARS-CoV-2 nasopharyngeal swab ([Table 1](#tbl0005){ref-type="table"} ).Table 1Summary of clinical parameters and clinical course in seven patients with suspected SARS-CoV-2 after urological surgery[a](#tblfn0005){ref-type="table-fn"}.Table 1Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7GenderMaleMaleMaleFemaleFemaleFemaleMaleIndication for PO SARS-CoV-2 NSPyrexia, dry cough, malaisePyrexia, dry cough, dyspnoeaDry cough, dyspnoea, malaisePyrexia, dry coughPyrexiaPyrexiaPyrexia, dry coughSARS-CoV-2 DxYesYesYesNo (atelectasis)No (atelectasis)No (pyelonephritis)No (atelectasis)Positive SARS-CoV-2 NSYesYesNoNoNoNoNoAge (yr)53826770495677ProcedureLNTURBTRARPLNCystectomyCystectomyNephroureterectomyComorbiditiesHTNHTN, ex-smokerSmokerHTN, provoked DVTThrombophiliaHTNT1DM, HTNASA score3322323BMI (kg/m^2^)33.629.631.635.534.82533Time to Dx after surgery (d)1442024262Onset to Dx (d)3611111Date of SARS-CoV-2 DxApril 12, 2020April 18, 2020April 9, 2020N/AN/AN/AN/AICU support requiredNoNoYesNoNoNoNoFeverYesYesYesYesYesYesYesHighest fever (°C)39.14035.538.238.539.138.2DiarrhoeaNoNoNoNoNoNoNoHighest CRP (mg/l)269272.9107Not measured282186224LymphopeniaNoYesNoNoYesYesYesElevated sCr (μmol/l)176194161127NoNo258SARS-CoV-2--related eventsViral pneumonia: bilateral pleural effusions and patchy GGO on CXRViral pneumonia: GGO changes involving all lobes of both lungs on CT, MIOverwhelming ARDS within 4 h of readmissionN/A (atelectasis)N/A (atelectasis)N/AN/ASARS-CoV-2 treatmentNIV (CPAP/BiPAP)NIV (CPAP/BiPAP)VentilatedN/AN/AN/AN/ASARS-CoV-2 outcomesDischarged after 27 dCurrent inpatient (20 d after Dx)MortalityN/AN/AN/AN/A[^1][^2]

Data on the safety of surgical procedures in SARS-CoV-2 hospitals are important so that knowledge can be provided to surgeons on perioperative SARS-CoV-2--related outcomes during the COVID-19 pandemic. At present, various guidelines and opinions on preoperative SARS-CoV-2 screening protocols are available (eg, thorax computed tomography vs nasopharyngeal swab). However, such guidelines are limited by their level of evidence as, to date, they are based on expert opinion without robust prospective data [@bib0020]. Our current departmental policy is to perform a screening telephone interview 7 d before surgery and to advise elective patients with asymptomatic COVID-19 to self-isolate. A second screening telephone interview in conjunction with a nasopharyngeal swab is carried out 24--48 h before all elective surgery cases.

Our short-term findings demonstrate that the incidence and mortality rate of symptomatic SARS-CoV-2 infection is approximately 3% and 1%, respectively, among patients undergoing urological surgery during the pandemic. Diagnosis of postoperative SARS-CoV-2 infection is difficult, as symptoms mimic common postoperative surgical complications (eg, atelectasis). Patients who experience postoperative COVID-19 are likely to develop significant respiratory complications and have a prolonged inpatient admission. Information from this study will enable surgeons to balance the risk of delaying urgent surgical procedures against the increased morbidity and mortality associated with SARS-CoV-2 infection.
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The following are Supplementary data to this article:

Supplementary material related to this article can be found, in the online version, at doi:<https://doi.org/10.1016/j.eururo.2020.05.012>.

[^1]: ARDS = acute respiratory distress syndrome; ASA = American Society of Anesthesiologists; BiPAP = bilevel positive airway pressure; BMI = body mass index; CPAP = continuous positive airway pressure; CRP = C-reactive protein; CT = computed tomography; CXR = chest X-ray; DVT = deep vein thrombosis; Dx = diagnosis; GGO = ground glass opacity; HTN = hypertension; ICU = intensive care unit; LN = laparoscopic nephrectomy; MI = myocardial infarction; N/A = not applicable; NIV = noninvasive ventilation; NS = nasopharyngeal swab; PO = postoperative; RARP = robot-assisted radical prostatectomy; sCr = serum creatinine; T1DM = type 1 diabetes mellitus; TURBT = transurethral resection of bladder tumour.

[^2]: Patients 1 and 2 had a positive PO NS for SARS-CoV-2. Patient 3 had a clinical diagnosis of SARS-CoV-2. Patients 4--7 had one or more symptoms of SARS-CoV-2 and a negative NS for SARS-CoV-2.
